What's New

Last Posted: May 18, 2019

• Cystic Fibrosis Patients Turn to Experimental Phage Therapy
  A Ellin, NY Times, May 17, 2019
• Automated deep-neural-network surveillance of cranial images for acute neurologic events.
  Titano Joseph J et al. Nature medicine 2018 24(9) 1337-1341
• Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
  Maggio Valerio et al. PloS one 2018 13(12) e0208924
• Isocitrate dehydrogenase mutations in defining the biology of and supporting clinical decision making in glioblastoma.
  Kálovits Ferenc et al. Ideggyogyaszati szemle 2018 Jul 71(7-08) 237-247
• Omics techniques and biobanks to find new biomarkers for the early detection of acute lymphoblastic leukemia in middle-income countries: a perspective from Mexico.
  Aguirre-Guillén William Alejandro et al. Boletin medico del Hospital Infantil de Mexico 74(3) 227-232
• Point-of-care, smartphone-based, dual-modality, dual-view, oral cancer screening device with neural network classification for low-resource communities.
  Uthoff Ross D et al. PloS one 2018 13(12) e0207493
• Using two smartphones to look for corneal cystine crystals.
  Bose Swaha et al. Digital journal of ophthalmology : DJO 2019 Jan 25(1) 12-15
• Novel Nanochip Paves Way for Early Ovarian Cancer Detection.
  Abbasi Jennifer et al. JAMA 2019 May (18) 1759
• A 4-gene panel predicting the survival of patients with glioblastoma.
  Guo Xiao-Xia et al. Journal of cellular biochemistry 2019 May
• A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
  Wiens Katie et al. American journal of medical genetics. Part A 2019 May
• Accuracy in risk understanding among BRCA1/2-mutation carriers.
  Speiser Dorothee et al. Patient education and counseling 2019 May
• Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
  Haffner Dieter et al. Nature reviews. Nephrology 2019 May
• Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.
  Nicolussi Arianna et al. PeerJ 2019 7e6661
• Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.
  Paquin Ryan S et al. Orphanet journal of rare diseases 2019 May 14(1) 102
• Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.
  Pratt Victoria M et al. The Journal of molecular diagnostics : JMD 2019 May
• The influence of BRCA variants of unknown significance on cancer risk management decision-making.
  Chern Jing Yi et al. Journal of gynecologic oncology 2019 Feb
• Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
  Vos Janet R et al. Journal of the National Cancer Institute 2019 May
• Deep learning-based survival prediction of oral cancer patients.
  Kim Dong Wook et al. Scientific reports 2019 May 9(1) 6994
• Developing a Diagnostic Decision Support System for Benign Paroxysmal Positional Vertigo Using a Deep-Learning Model.
  Lim Eun-Cheon et al. Journal of clinical medicine 2019 May 8(5)
• Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
  McGee Jacob et al. Journal of oncology 2019 20196029097